Macular Degeneration: Latest Updates & Interesting Retinal Cases
Date: 31/05/2022 (AEST)
Venue: Friendly Society Private Hospital, 19-23 Bingera Street, Bundaberg, QLD, 4670
Provider: Bundaberg Eye Clinic
Contact: Rachael, [E] manager@bundabergeye.com.au, [P] 07 4153 4490
Learning Objectives
- The participants will have an understanding of the current VEGF treatments and indications for use.
- The participants will gain an understanding of new VEGF therapies coming to the market.
- The participants will gain an understanding of how COVID can affect the eye
- The participants will be presented with different case studies and will confirm diagnosis and treatment with Dr McLean
- The participants will have the opportunity to put their ophthalmology questions to Dr McLean for discussion and consideration
Max CPD hours awarded: 2.75
Session Information
| Name |
|---|
| Macular Degeneration - Current Therapies |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| Future VEGF Treatments in Macular Degeneration |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| Covid and the Eye |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| Interesting Retinal & Ophthalmology Cases |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.75 |
| Name |
|---|
| Open Q & A Session |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |